Form 4: McKesson Executive Sells Shares Under Pre-Arranged 10b5-1 Trading Plan

Thomas L. Rodgers, EVP, Chief Strategy & BDO of McKesson Corp., reported the sale of 510 shares of common stock for approximately $366,134 under a Rule 10b5-1 trading plan.

Summary

• Thomas L. Rodgers, Executive Vice President, Chief Strategy & Business Development Officer of McKesson Corp. (MCK), reported a sale of company common stock.
• The transaction involved the disposition of 510 shares of common stock.
• The sale occurred on May 28, 2025, at a price of $717.91 per share.
• The total value of the shares sold was approximately $366,134.10 (510 shares * $717.91/share).
• This sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan, which was adopted on August 17, 2024.
• Following this transaction, Mr. Rodgers directly beneficially owns 5,435 shares of McKesson Corp. common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine disclosure of an insider stock sale conducted under a pre-arranged 10b5-1 plan, which is a common practice for executive financial planning and does not typically signal positive or negative company performance or outlook.

Future Outlook

NA

Industry Context

This Form 4 filing reports a routine insider transaction for McKesson Corp., a leading pharmaceutical distributor and healthcare information technology company. Such transactions, especially when conducted under a Rule 10b5-1 plan, are common among executives for personal financial planning and generally do not reflect specific industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: May note the executive's sale, but the 10b5-1 plan context generally mitigates concerns about insider sentiment regarding the company's future performance.

Key Dates

Keywords

McKesson, MCK, Form 4, Insider Trading, Stock Sale, Executive Compensation, Rule 10b5-1, Thomas L. Rodgers, Corporate Governance